...
首页> 外文期刊>European review for medical and pharmacological sciences. >Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma
【24h】

Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma

机译:长非编码RNA AK021443的表达增加预示肝细胞癌的临床预后较差

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Dysregulation of long non-coding RNAs (lncRNAs) plays critical roles in the process of carcinogenesis and tumor progression. LncRNA AK021443 (AK021443) has been reported to serve as a tumor promoter in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the expression of AK021443 and its prognostic value in HCC.. PATIENTS AND METHODS: Quantitative Real-Time-PCR was used to examine the expression of AK021443 in 193 HCC tissues and adjacent non-tumor tissues. The correction between AK021443 expression and clinicopathological characteristics was evaluated with Chi-square test. To determine its prognostic value, overall survival was evaluated using the Kaplan-Meier method. Univariate and multivariate analyses were performed to analyze the prognostic significance of AK02144 expression. RESULTS: The results revealed that AK021443 expression levels were significantly higher in HCC tissues than in the corresponding noncancerous tissues (p0.01). Besides, high AK021443 expression was correlated with poor tumor differentiation (p = 0.002), advanced clinical stage (p=0.001) and positive lymph node metastasis (p=0.005). In addition, the Kaplan-Meier survival curves revealed that HCC patients with high AK021443 expression level had shorter overall survival than those with low AK021443 expression level (p=0.0005). Finally, the multivariable analysis suggested that increased AK021443 expression was an independent prognostic factor of overall survival in HCC patients. CONCLUSIONS: Our findings indicated that AK021443 may play an important role in tumorigenesis and progression and would be a powerful marker to predict the prognosis of HCC patients.
机译:目的:长非编码RNA(lncRNA)的失调在癌变和肿瘤进展过程中起关键作用。据报道,LncRNA AK021443(AK021443)在肝细胞癌(HCC)中起肿瘤启动子的作用。这项研究的目的是调查AK021443在肝癌中的表达及其预后价值。病人与方法:采用定量实时荧光定量PCR检测AK021443在193例HCC组织和邻近的非肿瘤组织中的表达。用卡方检验评估AK021443表达与临床病理特征之间的校正。为了确定其预后价值,使用Kaplan-Meier方法评估了总生存期。进行单因素和多因素分析以分析AK02144表达的预后意义。结果:结果显示,HCC组织中AK021443的表达水平明显高于相应的非癌组织(p <0.01)。此外,AK021443高表达与肿瘤分化差(p = 0.002),临床分期(p = 0.001)和淋巴结转移阳性(p = 0.005)相关。此外,Kaplan-Meier生存曲线显示,AK021443表达水平高的HCC患者的总生存期比AK021443表达水平低的HCC患者的生存期短(p = 0.0005)。最后,多变量分析表明,AK021443表达的增加是HCC患者总体生存的独立预后因素。结论:我们的研究结果表明,AK021443可能在肿瘤发生和发展中起重要作用,并将成为预测HCC患者预后的有力标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号